July 6, 2020 / 8:02 AM / a month ago

BRIEF-Curevac Receives EUR 75 Million Vaccine Financing From European Commission

July 6 (Reuters) - CUREVAC AG:

* EIB AND EUROPEAN COMMISSION PROVIDE CUREVAC WITH A EUR 75 MILLION FINANCING FOR VACCINE DEVELOPMENT AND EXPANSION OF MANUFACTURING

* EUROPEAN INVESTMENT BANK AND CUREVAC SIGN EUR 75 MILLION LOAN AGREEMENT FOR DEVELOPMENT AND LARGE-SCALE PRODUCTION OF VACCINES, INCLUDING CUREVAC’S VACCINE CANDIDATE AGAINST SARS-COV-2

* EIB LOAN WILL SUPPORT CUREVAC’S ACTIVITIES TO COMPLETE ITS NEW MESSENGER RIBONUCLEIC ACID (MRNA) PRODUCTION FACILITY IN TÜBINGEN, GERMANY

* TRANSACTION IS FINANCED UNDER INFECTIOUS DISEASES FINANCE FACILITY OF HORIZON 2020, EU RESEARCH AND INNOVATION PROGRAMME FOR 2014-2020

* EIB FINANCING WILL BE PROVIDED IN THREE EUR 25 MILLION TRANCHES UPON COMPLETION OF PRE-DEFINED MILESTONES Source text for Eikon: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below